Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Apellis Pharmaceuticals Inc (APLS)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Apellis Pharma's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
52.09 +0.59    +1.15%
14:15:57 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 546,284
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 50.70 - 53.05
Apellis Pharma 52.09 +0.59 +1.15%

Apellis Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Apellis Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

767

Equity Type

ORD

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, and hematopoietic stem cell transplantation-associated thrombotic microangiopathy; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops APL-3007, a small interfering RNA, or siRNA, which is in a Phase 1 clinical trial, as well as an oral complement inhibitor that is in preclinical development. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam’s base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

Contact Information

Address 100 Fifth Avenue
Waltham, 02451
United States
Phone 617 977 5700
Fax -
Web www.apellis.com

Top Executives

Name Age Since Title
Lokchung Chan 70 2013 Independent Chairman of the Board
Cedric Francois 49 2009 Co-Founder, President, CEO & Director
Stephanie Monaghan O’Brien 64 2013 Independent Director
Alec Machiels 50 2009 Co-Founder & Director
Jason Scott Slakter 65 2015 Member of AMD Scientific Advisory Board
Gabriel J. Coscas - 2015 Member of AMD Scientific Advisory Board
Marsha Wills-Karp - - Member of Pulmonology Scientific Advisory Board
Paul R. Fonteyne 62 2020 Independent Director
A. Sinclair Dunlop 51 2010 Independent Director
Dave Singh - 2015 Member of Pulmonology Scientific Advisory Board
Claudia Kemper - 2015 Member of Pulmonology, AMD & PNH Scientific Advisory Board
Robert A. Brodsky - 2015 Member of PNH Scientific Advisory Board
Johanna M. Seddon - 2015 Member of AMD Scientific Advisory Board
Susan M. Lea - 2015 Member of Pulmonology, AMD & PNH Scientific Advisory Board
Philip J. Rosenfeld - 2015 Member of AMD Scientific Advisory Board
Bruno Crestani - 2015 Member of Pulmonology Scientific Advisory Board
Toby Maher - 2015 Member of Pulmonology Scientific Advisory Board
Janet Stoltz Sunness - 2015 Member of AMD Scientific Advisory Board
Michael Yeadon - 2015 Member of Pulmonology Scientific Advisory Board
Carl Atkinson - 2015 Member of Pulmonology Scientific Advisory Board
Jaroslaw Maciejewski - 2015 Member of PNH Scientific Advisory Board
Peter Hillmen - 2015 Head of Hematology Engagement & Member of PNH Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

APLS Comments

Write your thoughts about Apellis Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lucian Vlad
Lucian Vlad Nov 01, 2023 12:28PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Day's Range: 45.75 - 51.00 and maybe more green candles arrive
Reply
0 0
Report
Lucian Vlad
Lucian Vlad Aug 21, 2023 10:29AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
in max 3 month APLS will be above 50USD, pls see the main big investors list  , and take actions in consequences :)
Reply
1 0
Report
Ali Nikpay
Ali Nikpay Aug 11, 2023 3:45PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Selling 1/3 of position
Reply
0 0
Report
Antoine Neaime
Antoine Neaime Aug 03, 2023 4:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
big potential here, easy 50% can be made
Reply
1 0
Report
Hasan YELOK
Hasan YELOK Aug 03, 2023 4:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Yeah, but it just keeps going down every day.
Reply
1 0
Report
Ali Nikpay
Ali Nikpay Aug 01, 2023 1:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buying it
Reply
1 0
Report
Coşkun YILDIZ
Coşkun YILDIZ Aug 01, 2023 5:54AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
7 people has some retina damaged probably this news impact the stock. Check news
Reply
0 0
Report
Giuseppe Di Natale
Giuseppe Di Natale Aug 01, 2023 5:54AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
7 on over 60.000…
Reply
1 0
Report
Coşkun YILDIZ
Coşkun YILDIZ Aug 01, 2023 5:54AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
60000 people or pieces of shrinkage pieces..
Reply
0 0
Report
Ionut Daniel Zidaru
Ionut Daniel Zidaru Jul 31, 2023 9:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What is wrong with this stock?? The earnings are great, the news are great, but it deep 14%
Reply
3 0
Report
Hasan YELOK
Hasan YELOK Jul 31, 2023 9:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Tell me about it...
Reply
0 0
Report
Daniil Mosiyenko
Daniil Mosiyenko Jul 31, 2023 9:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Maybe manipulation from market-makers
Reply
0 0
Report
Antoine Neaime
Antoine Neaime Jul 31, 2023 9:59AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
will go up today maybe to 30
Reply
0 0
Report
Ali Nikpay
Ali Nikpay Jul 25, 2023 12:20AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buy it, short squeeze in few days
Reply
0 0
Report
Λάμπης Δημητριάδης
Λάμπης Δημητριάδης Jul 18, 2023 6:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
it's time to buy cheap.
Reply
2 0
Report
Abdullah Melik Aytürk
Abdullah Melik Aytürk Jul 18, 2023 6:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
are you sure, don't you think it will lose more value?
Reply
0 0
Report
Λάμπης Δημητριάδης
Λάμπης Δημητριάδης Jul 18, 2023 6:11PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think the best time for buy it's October November. they lose more value all summer
Reply
0 0
Report
Omar Corona
Omar Corona Oct 14, 2021 5:23PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This is the kind of stocks you normally don't have the chance to buy cheap. One thing semi-wrong and it tumbled 40%. But, it doesn't justify today's price. This will skyrocket also with one good thing. One huge investor just left the company but also left cheap price stock.
Reply
0 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email